新聞/Reuters/India's Torrent Pharma's profit slips as R&D costs outweigh domestic demandIndia's Torrent Pharma's profit slips as R&D costs outweigh domestic demand閱讀全文無限制訪問Reuters以及TradingView所有其他新聞來源的文章。繼續閱讀